National Collaborative Issues Call to Action against COVID-19
With a vaccination campaign still in initial stages, Americans continue to experience record infection and mortality rates from COVID-19. Now, the COVID Collaborative—a bipartisan group of national experts and institutions—has released its Call to Action, a set of recommendations to support state and local efforts against the pandemic.
Melanie Ott, MD, PhD, director of the Gladstone Institute of Virology, helped develop the recommendations as an expert contributor to the collaborative, which brings together experts in health, education, and economics. And as a leader in COVID-19 research, Gladstone is one of the group’s collaborating institutions.
“Biomedical and public health research are critical components of an effective pandemic response,” says Ott. “Gladstone researchers have contributed since day one, when many of our labs pivoted to focus on SARS-CoV-2, the virus that causes COVID-19.”
As outlined on the COVID Collaborative’s new website, the new Call to Action rests on five key pillars: testing, contact tracing, public health and social measures, vaccines and treatments, and standardized indicators to measure success across states.
The collaborative has already launched several initiatives in line with its recommendations. For instance, it helped develop a $50-million vaccination education campaign informed by a survey on vaccine hesitancy in Black and Latinx communities. It also contributed to a guide on improving online learning, a toolkit to help states promote mask wearing, and a guide to equitable vaccine distribution.
“Our unified plan could play a crucial role in ending the devastating spread of this disease,” Ott says. “To ensure success, state and local leaders will need to focus on equitable solutions that engage vulnerable communities.”
The COVID Collaborative is co-chaired by former Governor, Mayor, and US Senator Dirk Kempthorne of Idaho, and former Governor, business executive, and civil rights advocate Deval Patrick of Massachusetts. Its Call to Action has so far received bipartisan support from more than 10 state governors, including California’s Governor Gavin Newsom.
Up Next
Long COVID and Immune ‘Soldier’ Cells: A Q&A With Gladstone’s Nadia Roan
New research links long COVID to changes in virus-specific immune cells, particularly in women.
Gladstone Scientists Are Awarded $2 Million to Map How HIV Affects the Immune System
By uniting the power of single-cell sequencing, organoids, and artificial intelligence, scientists are entering a new era of HIV research.
Gladstone Launches Center for PhAIge Therapy to Harness AI in the Fight Against Drug-Resistant Infections
The center, funded by an NIH grant, will become one of three national centers dedicated to accelerating the development of phage therapy.
A New Pandemic Threat? Unpacking the Hantavirus Cruise Ship Outbreak
Gladstone virologist Melanie Ott explains why this rare, person-to-person hantavirus strain illustrates the need for diligent pandemic preparedness.
Get Involved
Join the Team
Our people are our most important asset. We offer a wide array of career opportunities both in our administrative offices and in our labs.
Open PositionsPartner With Us
Discoveries don’t stay in our labs. Gladstone facilitates spinout companies to advance promising therapies, shortening the path between scientific discovery and helping real patients.
Learn MoreGive
Your gift to Gladstone will allow our researchers to pursue high-quality science, focus on disease, and train the next generation of scientific thought leaders.
Donate Now